The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

Medicare announced Friday that it has selected 15 drugs, including the hugely popular medications Ozempic and Wegovy, used ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

A high dose of Novo Nordisk’s obesity drug Wegovy led patients to lose substantial weight in a clinical trial, but still less ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is ...

Drugmakers will have until the end of February to decide whether they want to participate in the second round of Medicare ...

Over the last year, weight loss jabs have become highly popular, particularly as the NHS began offering Wegovy in late 2023 and will start offering Mounjaro to patients in March 2025. There has also ...

He said he felt "blessed" to be given the drug. But the NHS spending watchdog NICE has ruled that each patient can only receive Wegovy for two years. And only a tiny proportion of the eligible 3.4 ...

An estimated 3.4 million Brits meet the criteria to receive a prescription for Wegovy and Mounjaro which would cost £10billion a year. All weight loss jabs, including Ozempic, contain semaglutide ...